A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
The Tory peer and former Marks & Spencer chief has been named as chairman of the 'In Campaign'.
Delicately worded memo by then press chief from 1985 is among cache of newly released documents from former PM's private files.
Cloud and showery rain may linger across the far northwest throughout Saturday.